|Free Dividend Report|
|Stock Splits Calendar|
|HTGM Stock Split History|
|Preferred Stock Newsletter|
|HTGM Options Chain|
|Stock Message Boards|
HTG Molecular Diagnostics (HTGM) has 1 split in our HTGM split history database. The split for HTGM took place on November 23, 2020. This was a 1 for 15 reverse split, meaning for each 15 shares of HTGM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as HTG Molecular Diagnostics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the HTGM split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into HTG Molecular Diagnostics shares, starting with a $10,000 purchase of HTGM, presented on a split-history-adjusted basis factoring in the complete HTGM split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-54.50%|
|About HTG Molecular Diagnostics|
|HTG Molecular Diagnostics is a commercial stage RNA platform-based life sciences company focused on developing medicine. Co.'s product and service solutions are based on its digital HTG EdgeSeq technology that enables RNA profiling using a small amount of biological sample, in liquid or solid forms. Co. markets proprietary molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. Co.'s marketed panels include: HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq Precision Immuno-Oncology Panel; HTG Lung Fusions Assay;HTG Autoimmune Panel; HTG EdgeSeq Immuno-Oncology Assay; and HTG Mouse mRNA Tumor Response Panel. According to our HTGM split history records, HTG Molecular Diagnostics has had 1 split.|
|HTGM Split History Table|
|11/23/2020||1 for 15|
|Healthcare Stock Splits|
|HTGM is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: HTGM shares outstanding history